Allopurinol
- Product NDC
- 43063-975
- 11-digit product format
- 430630975
- Labeler code
- 43063
- Product ID
- 43063-975_415f7450-75df-70e1-e063-6294a90a2e88
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Allopurinol
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Application
- ANDA071450
- Marketing category
- ANDA
- Marketing start
- 1987-01-09
- Substance
- ALLOPURINOL
- Active strength
- 100 mg/1
- Pharmacologic classes
- Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Allopurinol
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ALLOPURINOL | 100 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 63CZ7GJN5I |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 43063-975-20 | Allopurinol | 20 in 1 BOTTLE, PLASTIC | TABLET | 20 | | 16 |
| 43063-975-90 | Allopurinol | 90 in 1 BOTTLE, PLASTIC | TABLET | 90 | | 16 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 43063-975 | ALLOPURINOL TABLET [PD-RX PHARMACEUTICALS, INC.] | 15 | Current NDC, Legacy NDC, 2 package rows | 20240710_b2ab2389-ccaf-487b-9985-50e3539e7617.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 43063-975-20 | 43063097520 | 20 TABLET in 1 BOTTLE, PLASTIC (43063-975-20) | 20 tablet | 2019-06-14 | 0000-00-00 | No | No | Current |
| 43063-975-90 | 43063097590 | 90 TABLET in 1 BOTTLE, PLASTIC (43063-975-90) | 90 tablet | 2019-04-29 | 0000-00-00 | No | No | Current |